Plasma total homocysteine and cognitive performance in a volunteer elderly population.

Plasma total homocysteine and cognitive performance in a volunteer elderly population.

Bibliographic Details
Main Authors:	Budge, M, Johnston, C, Hogervorst, E, De Jager, C, Milwain, E, Iversen, S, Barnetson, L, King, E, Smith, A
Format:	Conference item
Published:	2000

Similar Items

Total plasma homocysteine, age, systolic blood pressure, and cognitive performance in older people.
by: Budge, M, et al.
Published: (2002)

Plasma total homocysteine and memory in the elderly: the Hordaland Homocysteine Study.
by: Nurk, E, et al.
Published: (2005)

Variability and determinants of total homocysteine concentrations in plasma in an elderly population.
by: Clarke, R, et al.
Published: (1998)

Early detection of isolated memory deficits in the elderly: the need for more sensitive neuropsychological tests.
by: de Jager, C, et al.
Published: (2002)

Serum levels of estradiol and testosterone and performance in different cognitive domains in healthy elderly men and women.
by: Hogervorst, E, et al.
Published: (2004)

Homocysteine, B vitamins, and cognitive deficit in the elderly.
by: Smith, A
Published: (2002)

Elevated plasma total homocysteine increased the risk of dementia in the elderly: Commentary
by: Sheehan, B, et al.
Published: (2002)

Elevated plasma total homocysteine levels increased the risk for dementia in the elderly.
by: Sheehan, B, et al.
Published: (2002)

Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease
by: Hogervorst, E, et al.
Published: (2002)

Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease.
by: Hogervorst, E, et al.
Published: (2002)

Serum total testosterone is lower in men with Alzheimer's disease.
by: Hogervorst, E, et al.
Published: (2001)

Polymorphisms in the catechol-O-methyltransferase (COMT) gene influence plasma total homocysteine levels.
by: Tunbridge, E, et al.
Published: (2008)

Sensitivity and specificity of neuropsychological tests for mild cognitive impairment, vascular cognitive impairment and Alzheimer's disease.
by: De Jager, C, et al.
Published: (2003)

The associations of age, cardiovascular morbidity, and plasma homocysteine with brain atrophy in stroke-free, nondemented older adults.
by: Budge, M, et al.
Published: (2004)

Homocysteine and cognitive function in the elderly: the Rotterdam Scan Study.
by: Prins, N, et al.
Published: (2002)

Evaluation of novel assays in clinical chemistry: quantification of plasma total homocysteine.
by: Nexo, E, et al.
Published: (2000)

Interactions among polymorphisms in folate-metabolizing genes and serum total homocysteine concentrations in a healthy elderly population.
by: Devlin, A, et al.
Published: (2006)

Cases with mild cognitive impairment and Alzheimer's disease fail to benefit from repeated exposure to episodic memory tests as compared with controls.
by: Schrijnemaekers, A, et al.
Published: (2006)

The association of betaine, homocysteine and related metabolites with cognitive function in Dutch elderly people.
by: Eussen, S, et al.
Published: (2007)

Homocysteine as a predictor of cognitive decline in Alzheimer's disease.
by: Oulhaj, A, et al.
Published: (2010)

Homocysteine as a predictor of cognitive decline in Alzheimer's disease
by: Oulhaj, A, et al.
Published: (2010)

Facts and recommendations about total homocysteine determinations: an expert opinion.
by: Refsum, H, et al.
Published: (2004)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial
by: De Jager, C, et al.
Published: (2012)

Elevated homocysteine is associated with increased rates of epigenetic aging in a population with mild cognitive impairment
by: Holmes, HE, et al.
Published: (2024)

Homocysteine, B vitamins, and cognitive impairment
by: Smith, A, et al.
Published: (2016)

Facts and recommendations about total homocysteine determinations: an expert opinion
by: Refsum, H, et al.
Published: (2004)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial.
by: de Jager, C, et al.
Published: (2012)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial
by: De Jager, C, et al.
Published: (2012)

Human plasma homocysteine levels are associated with the catechol-O-methyltransferase Val158Met polymorphism
by: Tunbridge, E, et al.
Published: (2007)

Homocysteine and brain atrophy on MRI of non-demented elderly.
by: den Heijer, T, et al.
Published: (2003)

Genetic and environmental influences on total plasma homocysteine and its role in coronary artery disease risk.
by: Ghassibe-Sabbagh, M, et al.
Published: (2012)

Genetic and environmental influences on total plasma homocysteine and its role in coronary artery disease risk
by: Ghassibe-Sabbagh, M, et al.
Published: (2012)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.
by: Smith, A, et al.
Published: (2010)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.
by: Smith, A, et al.
Published: (2010)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial
by: Smith, A, et al.
Published: (2010)

Relations of glutamate carboxypeptidase II (GCPII) polymorphisms to folate and homocysteine concentrations and to scores of cognition, anxiety, and depression in a homogeneous Norwegian population: the Hordaland Homocysteine Study.
by: Halsted, C, et al.
Published: (2007)

Vitamin B12 status and rate of brain volume loss in community-dwelling elderly
by: Vogiatzoglou, A, et al.
Published: (2008)

Vitamin B12 status and rate of brain volume loss in community-dwelling elderly.
by: Vogiatzoglou, A, et al.
Published: (2008)

Plasma homocysteine, type 2 diabetes and risk of coronary heart disease in the UKPDS
by: Holman, R, et al.
Published: (2001)

Mild cognitive impairment: Stability and predictability of neuropsychological test performance over time
by: de Jager, C, et al.
Published: (2004)